1. Evaluation of different cut-off points for IgG avidity and IgM in the diagnosis of acute toxoplasmosis in pregnant women participating in a congenital toxoplasmosis screening program.
- Author
-
Laguardia MC, Carellos EVM, Andrade GMQ, Carneiro M, Januário JN, and Vitor RWA
- Subjects
- Humans, Female, Pregnancy, Cross-Sectional Studies, Acute Disease, Adult, Toxoplasma immunology, Toxoplasmosis diagnosis, Toxoplasmosis immunology, Young Adult, Sensitivity and Specificity, Immunoglobulin M blood, Immunoglobulin G blood, Antibody Affinity, Antibodies, Protozoan blood, Toxoplasmosis, Congenital diagnosis, Toxoplasmosis, Congenital immunology, Pregnancy Complications, Parasitic diagnosis, Pregnancy Complications, Parasitic immunology
- Abstract
The main social impact of toxoplasmosis stems from its ability to be vertically transmitted. Postnatally acquired infection is generally asymptomatic in approximately 70-90% of cases, making diagnosis often dependent on laboratory tests using serological methods to search for anti-T. gondii antibodies. This study aimed to investigate the ability of the VIDAS TOXO IgG avidity and VIDAS TOXO IgM assays to confirm recent toxoplasmosis. In total, 341 pregnant women with suspected acute toxoplasmosis were systematically monitored in the Program for Control of Congenital Toxoplasmosis in Minas Gerais State, Brazil. We conducted an observational analytical-descriptive cross-sectional study and grouped according to clinical and laboratory criteria as having acute or chronic toxoplasmosis. The VIDAS TOXO IgG avidity and VIDAS TOXO IgM assays were evaluated to investigate the capacity to identify acute infection. IgG avidity showed good performance in identifying acute toxoplasmosis when the IgG avidity index was lower than or equal to 0.1. Values greater than or equal to 3.16 according to the TOXO IgM kit were associated with a greater chance of acute infection. These results may contribute to a more adequate diagnosis of acute gestational toxoplasmosis and, consequently, the avoidance of inadequate or unnecessary treatments.
- Published
- 2024
- Full Text
- View/download PDF